← Back to Search

Procedure

Partial Wrist Fusion Techniques for Wrist Arthritis (PARTE Trial)

N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participant has a stage II or III scapholunate advanced collapse (SLAC) or scaphoid nonunion advanced collapse (SNAC) wrist and is a surgical candidate for the included surgical interventions
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-weeks, 3-, 6-, 12-months post-surgery
Awards & highlights

PARTE Trial Summary

This trial is comparing two techniques for partial wrist fusion in people with arthritis caused by prior injury. One group will have a four-corner fusion, and the other group will have a three-corner or capitolunate fusion with triquetral excision.

Who is the study for?
This trial is for people with stage II or III wrist arthritis from SLAC or SNAC who need surgery. It's not for those who can't read English, lack a stable address, won't do follow-ups, have other wrist arthritis types, mental/physical issues preventing consent, major hand joint problems, past major wrist surgery, infections or neuromuscular conditions affecting the arm.Check my eligibility
What is being tested?
The study compares two partial wrist fusion surgeries in treating post-traumatic wrist arthritis: Group A gets four-corner arthrodesis without removing a bone called the triquetrum; Group B has three-corner arthrodesis with triquetral excision.See study design
What are the potential side effects?
Potential side effects of these surgical procedures may include pain at the site of operation, reduced range of motion in the wrist, possible nerve damage leading to numbness or tingling sensations and complications related to healing such as infection.

PARTE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a stage II or III wrist condition and am eligible for surgery.

PARTE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-weeks, 3-, 6-, 12-months post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-weeks, 3-, 6-, 12-months post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Grip Strength
Secondary outcome measures
Complications
Patient-Rated Wrist Evaluation (PRWE) Questionnaire
Patient-Reported Outcomes Measurement Information System® (PROMIS)
+4 more

PARTE Trial Design

2Treatment groups
Active Control
Group I: Group A: Partial Wrist Arthrodesis without Triquetral ExcisionActive Control1 Intervention
Four-Corner Arthrodesis
Group II: Group B: Partial Wrist Arthrodesis with Triquetral ExcisionActive Control1 Intervention
Three-Corner or Capitolunate Arthrodesis with Triquetral Excision

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
889 Previous Clinical Trials
385,014 Total Patients Enrolled
3 Trials studying Arthritis
1,021 Patients Enrolled for Arthritis
Arthritis Society CanadaUNKNOWN
Wrist Evaluation Canada (WECAN)UNKNOWN

Media Library

Four-Corner Arthrodesis (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04580225 — N/A
Arthritis Research Study Groups: Group A: Partial Wrist Arthrodesis without Triquetral Excision, Group B: Partial Wrist Arthrodesis with Triquetral Excision
Arthritis Clinical Trial 2023: Four-Corner Arthrodesis Highlights & Side Effects. Trial Name: NCT04580225 — N/A
Four-Corner Arthrodesis (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04580225 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the geographical reach of this experiment?

"Presently, 5 locations are actively recruiting participants for this medical study. These sites span from St Albert to Saskatoon and Calgary plus other cities. To save time and resources, it is recommended that patients select the closest option when enrolling in the trial."

Answered by AI

Is the age criterion for this experiment restricted to those under forty?

"To be included in this medical experiment, patients must be between the ages of 18 and 70. Alternatively, there are 106 studies for minors and 1086 trials geared towards seniors."

Answered by AI

Can you tell me the maximum number of participants this research involves?

"Affirmative, the information posted on clinicaltrials.gov indicates that this investigation is presently accepting participants. This study was initially uploaded to the website on July 1st 2021 and has been revised most recently on September 21st 2022. To conduct their research, 120 trial candidates must be sourced from five distinct sites."

Answered by AI

Are there any openings at this time for potential participants?

"Data on clinicaltrials.gov confirms that this medical experiment is currently seeking participants; the trial was first posted in July of 2021 and most recently updated September 21st 2022."

Answered by AI

Do I qualify to join this research initiative?

"To qualify for this medical trial, prospective participants should possess joint afflictions and be between 18 to 70 years of age. The research team aims to enrol 120 patients in total."

Answered by AI
~35 spots leftby Sep 2025